三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01530 三生制药

圣诞节休市 12-24 12:08:24

25.880

-0.360

-1.37%

最高26.520	最低25.720	成交量649.63万
今开26.520	昨收26.240	日振幅3.05%
总市值656.83亿	流通市值656.83亿	总股本25.38亿
成交额1.69亿	换手率0.26%	流通股本25.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01530","market":"HK","secType":"STK","nameCN":"三生制药","latestPrice":25.88,"timestamp":1766549304003,"preClose":26.24,"halted":0,"volume":6496267,"delay":0,"floatShares":2538000000,"shares":2538000000,"eps":0.9569921210690846,"marketStatus":"圣诞节休市","change":-0.36,"latestTime":"12-24 12:08:24","open":26.52,"high":26.52,"low":25.72,"amount":168696552,"amplitude":0.030488,"askPrice":25.88,"askSize":17000,"bidPrice":25.8,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":1.0639185468599335,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":7,"adr":0,"listingDate":1433952000000,"exchange":"SEHK","adjPreClose":26.24,"dividendRate":0.010003,"openAndCloseTimeList":[[1766539800000,1766548800000]],"volumeRatio":0.8389211210575563,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01530","defaultTab":"news","newsList":[{"id":"2594287939","title":"光鲜下的另一面，BD交易后股价不涨反跌成常态？专家：短期热度降低不是坏事","url":"https://stock-news.laohu8.com/highlight/detail?id=2594287939","media":"时代周报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594287939?lang=zh_cn&edition=full","pubTime":"2025-12-25 14:21","pubTimestamp":1766643688,"startTime":"0","endTime":"0","summary":"今年创新药企业频繁宣布BD交易，但从三季度以来，原本利好的消息却不被二级市场买账。最近一周，BD交易再掀一个小高潮。12月22日，先声药业（02096.HK）宣布其附属公司江苏再明与Ipsen于12月19日签订独家授权许可协议。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512253601825588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1064130708.USD","LU1997244956.HKD","LU1146622755.USD","03692","LU1064131003.USD","09995","LU1997245177.USD","BK1589","BK0188","02509","LU0405327494.USD","BK0012","LU0405327148.USD","LU1781817850.SGD","BK0057","LU2097828474.EUR","01167","603087","BK0060","BK1593","BK1161","LU2495084118.USD","LU2488822045.USD","LU2097828557.USD","BK1574","000661","688428","688062","LU0502904849.HKD","BK0183","688336","BK0239","LU2097828631.EUR","02096","LU2148510915.USD","600276","002755","LU2097828714.EUR","LU1969619763.USD","02142","BK0028","BK0196","LU2580892862.HKD","01530","LU1328615791.USD","06978","688331","01801","LU2097828805.USD","LU1997245094.SGD"],"gpt_icon":0},{"id":"2594928361","title":"中国创新药“闯关”海外市场，如何实现全球价值兑现？","url":"https://stock-news.laohu8.com/highlight/detail?id=2594928361","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594928361?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:21","pubTimestamp":1766622108,"startTime":"0","endTime":"0","summary":"从长期来看，中国创新药市场规模有望持续增长，到2030年，中国创新药行业市场规模将接近2.3万亿元。完成审评5848个品种，同比增长9.49%；共计批准创新药上市54个品种。BD“造血”其实，2025年中国创新药行业最显著的特点，就是BD交易从“火热”到“价值兑现”的实质性跨越。这显示出中国创新资产在全球定价权的重要地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225082633a4751dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225082633a4751dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02615","BK1574","01530","06978","01276"],"gpt_icon":0},{"id":"2594285602","title":"三生制药12月24日主力净流出97.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2594285602","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594285602?lang=zh_cn&edition=full","pubTime":"2025-12-24 16:15","pubTimestamp":1766564157,"startTime":"0","endTime":"0","summary":"12月24日, 三生制药股价跌1.37%，报收25.88元，成交金额1.7亿元，换手率0.26%，振幅3.05%，量比0.38。三生制药今日主力资金净流出97.6万元，上一交易日主力净流入329.6万元。该股近5个交易日上涨0.31%，主力资金累计净流出2727.8万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.0亿元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224162157a47270df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251224162157a47270df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1593","01530","BK1161","BK1583"],"gpt_icon":0},{"id":"2593419285","title":"普华永道徐佳：中国创新药迎分水岭，量质转型呈分化格局","url":"https://stock-news.laohu8.com/highlight/detail?id=2593419285","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593419285?lang=zh_cn&edition=full","pubTime":"2025-12-23 20:54","pubTimestamp":1766494448,"startTime":"0","endTime":"0","summary":"普华永道中国医药医疗行业主管合伙人徐佳博士在接受21世纪经济报道记者专访时指出，中国创新药已进入“量质转型的分水岭阶段”，呈现“头部崛起、中小突围”的分化格局，而非行业全面复苏。当前，随着2025年国家医保药品目录正式披露，支付端对创新药的支持力度","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223205718a46f0791&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223205718a46f0791&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828474.EUR","LU0502904849.HKD","LU2097828714.EUR","BK1574","HK0000165453.HKD","06978","LU2328871848.SGD","01801","BK1583","LU2097828805.USD","LU1969619763.USD","LU2097828631.EUR","LU0455707207.USD","BK1161","LU2242644610.SGD","BK1589","LU2097828557.USD","09969","LU2488822045.USD","01530"],"gpt_icon":0},{"id":"2593412193","title":"每日卖空追踪 | 三生制药 12月23日卖空量成交212.4万股，卖空比例为15.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412193","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593412193?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:30","pubTimestamp":1766478622,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月23日，涨0.46%，卖空量成交212.4万股，较上一交易日减少14.37%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163253a46e1658&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223163253a46e1658&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"2593412167","title":"三生制药12月23日主力净流入329.6万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2593412167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593412167?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477750,"startTime":"0","endTime":"0","summary":"12月23日, 三生制药股价涨0.46%，报收26.24元，成交金额3.6亿元，换手率0.54%，振幅4.98%，量比0.67。三生制药今日主力资金净流入329.6万元，上一交易日主力净流出1789.1万元。该股近5个交易日上涨2.81%，主力资金累计净流出2463.2万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入1.3亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162043a6c50db7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223162043a6c50db7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","01530","BK1593","HK0000165453.HKD","BK1161"],"gpt_icon":0},{"id":"2593494070","title":"HTI医药2025年12月第三周周报：行业高景气，持续关注创新药械产业链","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494070","media":"海通国际","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593494070?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:07","pubTimestamp":1766477237,"startTime":"0","endTime":"0","summary":"2025年12月第三周A股医药板块表现与大盘相当。2025年12月第三周上证综指上涨0.03%，SW医药生物下跌0.1%，涨跌幅在申万一级行业中排名第19位。截至2025年12月19日，医药板块相对于全部A股的溢价水平目前处于正常水平，当前相对溢价率70.1%。2025年12月第三周美股标普医疗保健精选行业+0.6%，同期标普500+0.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223160731a6c4fe72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","HK0000252160.HKD","02487","LU2543165471.USD","01530","09939","01858","HK0000252152.HKD","09606","01276","HK0000500386.USD","02615","02359","02269","01801","06990","06078","BK1161","06160","BK1574"],"gpt_icon":0},{"id":"2593121604","title":"三生制药重组人血小板生成素注射液（特比澳®）慢性肝病相关血小板减少症适应症获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2593121604","media":"三生制药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593121604?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:07","pubTimestamp":1766473642,"startTime":"0","endTime":"0","summary":"News三生制药今日宣布，公司向国家药品监督管理局提交的三生制药重组人血小板生成素注射液（特比澳）新适应症已于日前获得批准，用于计划接受手术的慢性肝病相关血小板减少症成年患者。本次递交的CLDT临床研究评价了重组人血小板生成素注射液治疗计划接受侵入性手术的慢性肝病相关血小板减少症患者的有效性和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223151504a46dc09c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223151504a46dc09c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","01530","HK0000165453.HKD","BK1583"],"gpt_icon":1},{"id":"1130488131","title":"港股创新药概念股盘中拉升！石药集团涨超5%，荣昌生物涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1130488131","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130488131?lang=zh_cn&edition=full","pubTime":"2025-12-23 10:04","pubTimestamp":1766455472,"startTime":"0","endTime":"0","summary":"12月23日，港股创新药概念股盘中拉升，$石药集团(01093)$涨超5%，$恒瑞医药(01276)$、$三生制药(01530)$涨近3%，$先声药业(02096)$、$歌礼制药-B(01672)$、$康诺亚-B(02162)$涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"26e483f2c2080ad5ab71efdf30a08f1a","theme_name":"🔥热榜No.40 · 石药集团获主席蔡东晨增持引发股价大幅上涨","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","02162","02096","01477","01276","06978","01093","01672"],"gpt_icon":0},{"id":"2593456490","title":"港股延续反弹半导体与免税板块领涨，黄金等多种金属现货行情强势，机构看好储能龙头与家电巨头 | 港股日报","url":"https://stock-news.laohu8.com/highlight/detail?id=2593456490","media":"东方财富Choice...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593456490?lang=zh_cn&edition=full","pubTime":"2025-12-23 07:17","pubTimestamp":1766445438,"startTime":"0","endTime":"0","summary":"AI摘要：12月22日，港股延续反弹，三大指数集体收涨，恒生科技指数上涨0.87%。半导体、光通讯及免税板块表现强势，中国中免大涨近16%；三只新股上市首日均破发。机构方面，中金首次覆盖双登股份，美银看好美的集团，招银国际建议关注医药板块回调后的布局机会。展望后市，机构认为外部风险收窄，港股有望震荡上行，建议关注科技与消费板块。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233598697761.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["601888","BK4588","00300","000333","688981","01530","HSI","BK4585","01880","06960","HSTECH","SOXX","SMH"],"gpt_icon":1},{"id":"2593170975","title":"国产新药：十亿美金 BD 大单爆了","url":"https://stock-news.laohu8.com/highlight/detail?id=2593170975","media":"丁香园 Insight 数据库","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593170975?lang=zh_cn&edition=full","pubTime":"2025-12-22 07:50","pubTimestamp":1766361045,"startTime":"0","endTime":"0","summary":"Insight 数据库显示，国内十亿美金级别的交易中，跨国药企作为买方的占比接近五成，贡献了超过一半的交易额。其中，罗氏对中国创新药资产最为青睐，年内共达成了 3 笔大额交易。另外，从单笔金额来看，国内与 MNC 达成的交易有 5 笔超过了 50 亿美元，其中涉及的产品有COPD 新药、心血管 siRNA 疗法、PD1 双抗、ADC 等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222075317a6bec512&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222075317a6bec512&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2097828714.EUR","01801","LU2097828631.EUR","HK0000165453.HKD","LU2242644610.SGD","LU2328871848.SGD","BK1589","BK1583","LU1969619763.USD","LU2097828557.USD","01093","LU0455707207.USD","LU0502904849.HKD","LU2097828474.EUR","LU2097828805.USD","01530","LU2488822045.USD","BK1161"],"gpt_icon":0},{"id":"2593010194","title":"化妆品医美行业周报：林清轩上市在即 高端护肤赛道再添看点","url":"https://stock-news.laohu8.com/highlight/detail?id=2593010194","media":"申万宏源研究","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593010194?lang=zh_cn&edition=full","pubTime":"2025-12-22 00:00","pubTimestamp":1766332800,"startTime":"0","endTime":"0","summary":"本周化妆品医美板块表现强于市场。蔓迪国际深耕消费医疗，占据国内米诺地尔生发市场主要份额。三生蔓迪成立于2001 年，同年推出中国首款 5% 米诺地尔溶液剂并获批用于治疗雄激素性秃发。系列米诺地尔类产品连续十年稳居中国脱发药物市场及米诺地尔类药物市场零售额榜首，2024年市场份额分别达约57%及71%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222142628a6c0196a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222142628a6c0196a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1207","SG9999004311.SGD","LU2488822045.USD","01530","02367"],"gpt_icon":0},{"id":"2593121986","title":"医药生物行业周报：推荐CXO+科研服务板块的估值切换机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2593121986","media":"开源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593121986?lang=zh_cn&edition=full","pubTime":"2025-12-21 00:00","pubTimestamp":1766246400,"startTime":"0","endTime":"0","summary":"全球融资环境整体已处于回暖阶段，CRO 需求端已出现明确拐点，继续推荐2026 年创新药产业链整体性的机会。随着需求端持续改善，我们预计头部CXO+科研服务公司业绩有望持续改善，当前位置看2026 年估值性价比明显，首推相关标的估值切换的机会。医药布局思路及推荐标的整体上，我们持续看好创新药及其产业链，创新药方向重点推荐小核酸赛道的机会，并重点推荐头部CXO+科研服务估值切换的机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221173627a6bd0916&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221173627a6bd0916&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1593","BK1161","HK0000165453.HKD","01530","BK1583","02269","06127"],"gpt_icon":0},{"id":"2593121830","title":"医药生物行业：AI医疗应用商业化加速 重视AI医疗底部机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2593121830","media":"华福证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593121830?lang=zh_cn&edition=full","pubTime":"2025-12-21 00:00","pubTimestamp":1766246400,"startTime":"0","endTime":"0","summary":"AI 医疗商业化加速，底部掘金正当时：1）AI 医疗刚需体现：最新上线“蚂蚁阿福”流量凸显AI 医疗应用真实需求，智谱港股聆讯意味着资本加速认证新阶段；医疗大模型突破式演变，医疗机构大规模参与，截至2025年5 月第三方榜单中国内排名前100 的医院已全部完善大模型部署，多科室应用全场景辅助治疗型AI。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221170630a6bcf9db&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251221170630a6bcf9db&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1589","BK1100","BK1583","BK1585","00853","01530"],"gpt_icon":0},{"id":"2592117971","title":"三生制药张昊：多数创新药企出海仍依赖代理商，海外市场布局紧迫性提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2592117971","media":"钛媒体快报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592117971?lang=zh_cn&edition=full","pubTime":"2025-12-19 17:48","pubTimestamp":1766137688,"startTime":"0","endTime":"0","summary":"钛媒体App 12月19日消息，钛媒体集团 2025 T-EDGE  12月8日-12月21日全球同步开启。会上，三生制药国际事业部负责人张昊表示，虽然中国创新药已经有了长足的进步，但放眼全球市场所占比重不高，仅有少数企业能在海外直接营销，多数企业仍依赖代理商开展业务，这更凸显了布局海外市场的紧迫性。所以，不管\"借船出海\"还是\"造船出海”，最终的目的都是渗透、占领海外市场，海外是中国创新药必须探索和抢占的巨大蓝海。（2025 T-EDGE）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219175045a6b699a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219175045a6b699a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1593","BK1574","BK1161","01530","06978","BK1583"],"gpt_icon":0},{"id":"2592726154","title":"每日卖空追踪 | 三生制药 12月19日卖空量成交306.7万股，卖空比例为12.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592726154","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592726154?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:30","pubTimestamp":1766133022,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月19日，涨2.99%，卖空量成交306.7万股，较上一交易日增加134.03%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163307a6b64388&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219163307a6b64388&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HK0000165453.HKD","BK1583","BK1593","01530","BK1161"],"gpt_icon":0},{"id":"1128015169","title":"港股异动 | 创新药概念股拉升，晶泰控股、三生制药涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128015169","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128015169?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:12","pubTimestamp":1766110365,"startTime":"0","endTime":"0","summary":"12月19日，港股创新药概念股拉升，$晶泰控股(02228)$、$三生制药(01530)$涨超6%，$药明生物(02269)$涨超5%，$石药集团(01093)$、$药明合联(02268)$、$康诺亚-B(02162)$涨超4%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"66afc1ba6d0078bbc724c4259409298b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02228","01530"],"gpt_icon":0},{"id":"2592542401","title":"三生制药盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592542401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592542401?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:02","pubTimestamp":1766109755,"startTime":"0","endTime":"0","summary":"2025年12月19日早盘10时02分，三生制药股票出现异动，股价快速上涨5.04%。截至发稿，该股报26.680港元/股，成交量533.479万股，换手率0.21%，振幅5.67%。三生制药股票所在的药品行业中，整体涨幅为0.34%。其相关个股中，三生制药、凯莱英、君圣泰医药-B涨幅较大，振幅较大的相关个股有三生制药、康臣药业、君圣泰医药-B，振幅分别为5.51%、4.37%、4.21%。三生制药公司简介：投资控股,及本集团主要在中国从事开发、生产、营销及销售生物医药产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219100235a6b4e12f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219100235a6b4e12f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01530","HK0000165453.HKD","BK1161","BK1593","BK1583"],"gpt_icon":0},{"id":"2592513686","title":"【券商聚焦】交银国际：临近年末 续看好新BD交易集中落地机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513686","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513686?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:20","pubTimestamp":1766107245,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周多项超10亿美元的BD交易相继落地，合作伙伴既有MNC也有中小型生物科技公司。临近年末，该机构继续看好新BD交易集中落地机会。展望2026 年，该机构认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势，后续选股逻辑或将重回基本面和估值，即关注存在基本面预期差、当前仍被低估的个股。","market":"sg","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971853","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0540923850.HKD","LU0588546209.SGD","LU1303224171.USD","BK1191","LU0634319403.HKD","02228","LU1115378108.SGD","IE00B5MMRT66.SGD","09926","02367","BK1197","BK1583","LU0417516902.SGD","LU1251922891.USD","01530","LU0348825331.USD","LU1720050803.USD","LU0348784397.USD","01789","06160","01099","BK1500","IE00B543WZ88.USD","LU0348783233.USD","LU2328871848.SGD","BK1588","LU0417516738.SGD","LU0348766576.USD","BK1147","LU2476274720.SGD","02196","03329","HK0000165453.HKD","LU2399975544.HKD","02268","03933","BK1585","LU2778985437.USD","LU0561508036.HKD","BK1617","BK1593","SG9999014674.SGD","LU1770034418.SGD","09688","LU0348735423.USD","LU1794554557.SGD","LU2488822045.USD","LU0417516571.SGD","LU2476274308.USD","LU0307460666.USD"],"gpt_icon":0},{"id":"2592072133","title":"每日卖空追踪 | 三生制药 12月18日卖空量成交50.6万股，卖空比例为3.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592072133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592072133?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:30","pubTimestamp":1766046621,"startTime":"0","endTime":"0","summary":"三生制药北京时间12月18日，跌1.55%，卖空量成交50.6万股，较上一交易日减少89.2%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163317a45aa181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218163317a45aa181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1583","01530","HK0000165453.HKD","BK1593"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.3sbio.com","stockEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":-0.1684},{"period":"3month","weight":-0.1576},{"period":"6month","weight":0.1493},{"period":"1year","weight":3.3119},{"period":"ytd","weight":3.2905}],"compareEarnings":[{"period":"1week","weight":0.0137},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0251},{"period":"6month","weight":0.0632},{"period":"1year","weight":0.2846},{"period":"ytd","weight":0.2871}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"3SBio Inc是一家主要从事生物制药产品的开发、生产、市场推广及销售的投资控股公司。该公司的主要产品包括特比澳、益比奥、益赛普、赛普汀等生物药物以及蔓迪、丽美治等小分子药物。该公司还从事为客户提供多种生物药的研发生产以及治疗技术平台服务的合同开发与生产运营（CDMO）业务。该公司的产品主要应用于血小板减少症（CIT）、慢性肾病（CKD）引起的贫血症、治疗化疗引起的贫血症（CIA）、强直性嵴柱炎（AS）及银屑病等。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.003687},{"month":2,"riseRate":0.5,"avgChangeRate":0.007795},{"month":3,"riseRate":0.8,"avgChangeRate":0.121345},{"month":4,"riseRate":0.4,"avgChangeRate":-0.014398},{"month":5,"riseRate":0.7,"avgChangeRate":0.109101},{"month":6,"riseRate":0.8,"avgChangeRate":0.036581},{"month":7,"riseRate":0.090909,"avgChangeRate":-0.038254},{"month":8,"riseRate":0.363636,"avgChangeRate":-0.014022},{"month":9,"riseRate":0.636364,"avgChangeRate":0.027455},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.018307},{"month":11,"riseRate":0.727273,"avgChangeRate":0.059913},{"month":12,"riseRate":0.454545,"avgChangeRate":-0.040379}],"exchange":"SEHK","name":"三生制药","nameEN":"3SBIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三生制药,01530,三生制药股票,三生制药股票老虎,三生制药股票老虎国际,三生制药行情,三生制药股票行情,三生制药股价,三生制药股市,三生制药股票价格,三生制药股票交易,三生制药股票购买,三生制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三生制药(01530)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三生制药(01530)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}